Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2018 | 12-2017 | 09-2017 | 06-2017 | |
Sales | 23,411 | 0 | 27,146 | 11,142 |
Cost of Goods | 5,636 | N/A | 4,880 | 5,141 |
Gross Profit | 17,775 | N/A | 22,266 | 6,001 |
Operating Expenses | 13,106 | 0 | 12,725 | 10,201 |
Operating Income | 5,305 | N/A | 10,421 | -4,059 |
Interest Expense | 1,927 | 0 | 1,970 | 1,949 |
Other Income | 721 | 0 | 0 | 111 |
Pre-tax Income | 4,099 | 0 | 8,451 | -5,897 |
Net Income Continuous | 4,099 | N/A | 8,451 | -5,897 |
Net Income | $4,099 | $N/A | $8,451 | $-5,897 |
EPS Basic Total Ops | 0.27 | N/A | N/A | N/A |
EPS Basic Continuous Ops | 0.27 | N/A | N/A | N/A |
EPS Diluted Total Ops | 0.27 | N/A | N/A | N/A |
EPS Diluted Continuous Ops | 0.27 | N/A | N/A | N/A |
EBITDA(a) | $6,716 | $N/A | $11,849 | $-4,059 |